| 发明名称 |
2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN- ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS 23-[12-C]-5(1H)- A2(LP- PLA2) |
| 摘要 |
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease. |
| 申请公布号 |
HK1216425(A1) |
申请公布日期 |
2016.11.11 |
| 申请号 |
HK20160104389 |
申请日期 |
2016.04.18 |
| 申请人 |
GlaxoSmithKline Intellectual Property Development |
发明人 |
SANG, Yingxia;WAN, Zehong;ZHANG, Qing |
| 分类号 |
C07D;A61K;A61P |
主分类号 |
C07D |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
